-
Additional file 4: of STAT3 exacerbates survival of cancer stem-like tumorsph...
Figure S3. Higher levels of PDGFA are associated with overall survival in patients with CRC in the database PROGgeneV2. (TIF 226Â kb) -
dedup_wf_001--fa7024c108bae0d7ff5e4b294e4dcc21
Additional file 3: Figure 3-supplementary: The daily (A), weekly (B), monthly (C), and overall (D) prevalence of GERD symptoms in Iranian females. -
Clinicopathological features, surgical strategy and prognosis of duodenal gas...
Abstract Background The relatively low incidence of duodenal gastrointestinal stromal tumors (GISTs) and the unique anatomy make the surgical management and outcomes of this... -
PLoSOne GApaper data
This data file consists raw data used to generate results published in PLOS ONE article titled "Trends and determinants of gastric bacterial colonization of preterm neonates in... -
Additional file 1: of Efficacy and safety of bevacizumab plus chemotherapy co...
Quality assessment (risk of bias) of randomized studies evaluating bevacizumab plus chemotherapy in patients with mCRC in first line chemotherapy. (DOCX 46 kb) -
Additional file 7 of Epidemiology of gastroesophageal reflux disease in Iran:...
Additional file 7: Figure 7-supplementary: The daily (A), weekly (B), monthly (C), and overall (D) prevalence of heartburn in Iranian females. -
Additional file 10: of IL-17 signalling restructures the nasal microbiome and...
Raw OTU counts from Il17ra animals at 14 days after colonization. (CSV 49 kb) -
High serum MMP-14 predicts worse survival in gastric cancer data
High serum MMP-14 predicts worse survival in gastric cancer data -
Additional file 4 of Epidemiology of gastroesophageal reflux disease in Iran:...
Additional file 4: Figure 4-supplementary: Publication bias for daily (A), weekly (B), monthly (C), and overall (D) prevalence of GERD symptoms. -
Additional file 9: of IL-17 signalling restructures the nasal microbiome and ...
Raw OTU counts from Il17ra animals at 7 days after colonization. (CSV 70 kb) -
Additional file 1 of Epidemiology of gastroesophageal reflux disease in Iran:...
Additional file 1: Figure 1- supplementary: The sensitivity analysis for daily (A), weekly (B), monthly (C), and overall (D) prevalence of GERD symptoms in Iranian population. -
dedup_wf_001--a4c7ad7cfe80bb8cc581f08ee8dd6f18
Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative? -
Additional file 8 of Epidemiology of gastroesophageal reflux disease in Iran:...
Additional file 8: Figure 8-supplementary: Publication bias for daily (A), weekly (B), monthly (C), and overall (D) prevalence of heartburn. -
Epidemiology of gastroesophageal reflux disease in Iran: a systematic review ...
Abstract Background Gastroesophageal reflux disease (GERD), which leads to acid reflux into the esophagus, is a common gastrointestinal disorder. Several studies have shown the... -
Additional file 4: of On Predicting lung cancer subtypes using ‘omic’ data fr...
Appendix A shows the Cancer Genome Atlas annotations to identify the types of samples used in this study.Appendix B shows additional performance measures for the models... -
MOESM4 of Diagnostic value of plasma HSP90α levels for detection of hepatocel...
Additional file 4: The raw data of hepatocellular carcinoma patients cohort. -
dedup_wf_001--da27e0a2dc14066e78e0c3440fdc2e6a
Full model description and additional supplementary Figure S1-S6. This document includes a complete model description, including parameters, assumptions, mathematical... -
Additional file 1: of CAFs secreted exosomes promote metastasis and chemother...
Figure S1. Isolation and characterization of matched CAFs and counterpart NFs from CRC patients. Figure S2. CAFs promote migration, invasion, and chemotherapy resistance in CRC.... -
Additional file 1: of Efficacy and safety of bevacizumab plus chemotherapy co...
Quality assessment (risk of bias) of randomized studies evaluating bevacizumab plus chemotherapy in patients with mCRC in first line chemotherapy. (DOCX 46 kb) -
Additional file 3 of Using the Cochrane Central Register of Controlled Trials...
Additional file 3: Appendix S2. Reference list of included Cochrane Reviews.
